XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows
$ in Thousands
 3 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Cash flows from operating activities:    
Net loss $ (110,228) $ (74,151)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation 30,632 26,815
Loss on non-marketable and marketable equity investments 2,418 3,009
Deferred tax expense 1,797 1,261
Stock-based compensation 60,370 49,139
Gain on settlements of convertible notes, net 0 (10,324)
Amortization of acquired intangible assets 23,311 22,928
Impairment of long-lived assets 4,446 69
Loss on contingent consideration from sale of asset 268 0
Remeasurement of contingent consideration liabilities 5,603 (8,937)
Non-cash lease expense 7,052 6,806
Other 229 2,013
Changes in assets and liabilities:    
Accounts receivable, net (37,536) (25,434)
Inventory, net (1,065) (5,827)
Operating lease liabilities (6,603) (5,982)
Accounts payable and accrued liabilities (53,515) (4,817)
Other assets 6,586 13,622
Other liabilities (2,904) (1,161)
Net cash used in operating activities (82,311) (38,215)
Cash flows from investing activities:    
Purchases of marketable securities (177,325) (8,589)
Maturities and sales of marketable securities 43,978 121,332
Purchases of property, plant and equipment (37,649) (29,360)
Investments in privately held companies (237) (442)
Other investing activities (205) 0
Net cash provided by (used in) investing activities (171,438) 82,941
Payment, Tax Withholding, Share-Based Payment Arrangement (1,408) 964
Cash flows from financing activities:    
Proceeds from issuance of convertible notes 0 137,976
Other financing activities (1,594) (5,344)
Net cash provided by (used in) financing activities (3,002) 133,596
Effects of exchange rate changes on cash and cash equivalents (1,140) 550
Net increase (decrease) in cash, cash equivalents and restricted cash (257,891) 178,872
Cash, cash equivalents and restricted cash, beginning of period 609,675 242,790
Cash, cash equivalents and restricted cash, end of period 351,784 421,662
Supplemental disclosure of non-cash investing and financing activities    
Property, plant and equipment acquired but not paid 17,654 10,548
Supplemental disclosure of cash flow information:    
Interest paid 10,789 6,442
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 347,487 421,365
Restricted cash — included in other long-term assets, net 4,297 297
Total cash, cash equivalents and restricted cash $ 351,784 $ 421,662